Dr. Allan Frankel, a board-certified internist at GreenBridge Medical in Santa Monica, California, has treated patients with medical cannabis for the past 13 years. Frankel is particularly excited by the discovery of a new cannabinoid molecule, tetrahydrocannabivarin or THCV. While very similar to THC, which is the psychoactive part of marijuana, THCV is not psychoactive, but can still induce a sense of “focused euphoria.” “It’s a wonderful feeling, I think, for [those with] depression and anxiety,” Frankel says. It’s also helpful for pain, which is a really important medical need. Opioids are now killing an estimated 47,600 Americans annually,2 and we desperately need safer alternatives. Medical cannabis is one such alternative.
It’s becoming well known that older Americans are the country’s fastest-growing population of new cannabis users for medicinal purposes. More and more seniors are seeking refuge from polypharmacy, which is a culmination of five to maybe 25 costly pharmaceutical drugs being taken daily that actually diminish their quality of life. Fortunately, there are legitimate cannabis studies supporting seniors’ need for replacing toxic pharmaceutical drugs with medical cannabis, making it easier for baby boomers who never inhaled to switch from polypharmacy to cannabis. This article will cite some of those cannabis studies that relate specifically to the age-related discomforts, sleep disorders, lower energy, pains, and diseases that tarnish their "Golden Years."
Canada became one of the world’s first complete nations to legalize medical marijuana in 2001. This occurred after Terrance Parker went all the way to Ontario’s Court of Appeals in 2000 to declare the right to treat his epilepsy with the only thing that worked for him – cannabis. This court declared arresting Parker for using the only compound that worked for him was unconstitutional. Thus the Marijuana Medical Access Regulations (MMAR) created a national legal medical marijuana program allowing its use for chronic pain and diseases mainstream medicine fails at helping, such as cancer and AIDS. Since then, modifications and updates have created more liberal access to medical cannabis nationally throughout Canada more than any state in the United States. Recreational non-medical access to cannabis was approved in 2018. A recent University of Victoria survey was conducted among current legal medical marijuana users to determine the reasons and outcomes of using cannabis to replace prescribed pharmaceuticals or alcohol or other dangerous drugs. The researchers concluded: "The findings provide a granular view of patient patterns of medical cannabis use ...adding to a growing body of academic research suggesting that increased regulated access to medical and recreational cannabis can result in a reduction in the use of and subsequent harms associated with opioids, alcohol, tobacco, and other substances."
As has been reported numerous times here at Health Impact News for the past 6 years or so, the pharmaceutical industry has been desperate to find an Alzheimer's drug to market to an aging baby boomer population with ever increasing numbers of Alzheimer's Disease cases. And yet, billions of dollars have been invested in potential drugs only to see these drugs never make it out of the trial phase and come to market, because they do not significantly help Alzheimer's patients. Biogen and their partner Eisai are the latest pharmaceutical companies to throw in the towel regarding their Alzheimer's drug aducanumab, which has failed to make it out of phase 3 trials. Many drug researchers have now abandoned the theory of amyloid plaque accumulation in the brain as the causative factor of Alzheimer’s. Could aducanumab's failure be the last nail in the coffin for this theory, as natural approaches to Alzheimer's such as coconut oil and the ketogenic diet see more positive results?
In 1974, the Ford administration began bogus testing on monkeys as the science “proving” marijuana destroys brain cells. This helped support the “Reefer Madness” mania originated by the 1938 movie of the same name. It was great for the “Drug War” and “just say no” campaign. Since then, international studies have proven otherwise. But they were not publicized or used by politicians as much as the bogus study. The exponentially rising movement of states legalizing medical marijuana has provided us the anecdotal evidence that, contrary to the scare tactics used to discourage marijuana, the opposite is true. These anecdotal stories of cannabis healing, coupled with the expanding allowance of medical marijuana, have opened funding sources for "official" studies on cannabis and the brain. This time, studies will be focused on determining the highest and best use of cannabis strains instead of "proving" brain danger to justify banning the plant. These new studies are confirming cannabis as a healing agent for brain diseases and injuries, improving brain health.
There have been anecdotal reports and testimonies of arthritis sufferers getting effective relief from cannabis without adverse side effects, sometimes even reversing their arthritic conditions. There have also been several studies confirming the anecdotal successes with cannabis for treating arthritis with cannabis. A rare human study that clinically tested cannabis, and a massive review paper published recently that covered over 100 lab cell culture (in vitro) and animal (in vivo) studies testing cannabis for treating arthritis shows promising results for arthritis sufferers.
Study: Suicide Rates Lower in States with Legal Marijuana Sales – Medical Cannabis More Effective than Psych Drugs?
A study published a few years ago shows that in states where marijuana has been legalized, suicide rates have declined. The study, Medical Marijuana Laws and Suicides by Gender and Age, was published by the American Journal of Public Health and showed a reduction in suicide rates in states that allowed cannabis for medical use. Since this study was published, more states have adopted medical marijuana laws and some of those that have allowed cannabis for medical purposes have expanded to allowing cannabis for “recreational use” with controls and restrictions similar to alcohol consumption. So, the reduction in suicide rates may be an even greater reduction now than it was when this study was published.
Macular degeneration is the most common cause of blindness among people 55 and over who once had normal eyesight. That’s why it is often called age-related macular degeneration, or AMD. It can also occur rarely among younger people within a six to twenty year age span. Conventional medicine is relatively clueless about its cause, blaming it on imply aging or genetics for younger victims. It also falls short of effectively avoiding or treating it, considering it to be incurable and only poorly managed with harsh treatments. This article explores a newly discovered source of macular degeneration and its prevention as well as natural remedies that include eating the right foods and cannabis.
A recent 2018 animal study has indicated that cannabis with THC helps restore memory loss due to aging and dementia. This is what many medical cannabis users and experts already know. The human cannabis experience has outpaced mainstream science considerably. But it does help create some medical cannabis scientific credibility with mainstream medicine. The well known and often vilified cannabis compound known as THC (Δ9 aka delta 9 tetrahydrocannabinol) is the compound or cannabinoid that creates the euphoric “high.” Biased false claims that THC causes brain damage is the main reason why truly independent research is restricted from national funding in the USA unless it supports government marijuana danger claims. This new study, A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice, was conducted in Germany with national funding through the German Research Foundation (Deutsche Forschungsgemeinschaft). According to Newsweek magazine online and some other magazines and websites that covered this study, the study authors wrote: "Cannabis preparations and THC are used for medicinal purposes. They have an excellent safety record and do not produce adverse side-effects when administered at a low dose to older individuals. Thus, chronic, low-dose treatment with THC or cannabis extracts could be a potential strategy to slow down or even to reverse cognitive decline in the elderly."
A recent animal and human cell line culture study published August, 2018 confirms the anecdotal reports of healing inflammatory bowel and gut conditions with cannabis. Surprisingly, the study did not initially use cannabis. Its original purpose was to investigate the mechanics of inflammation in the gut using mice. They inadvertently discovered that impaired or insufficient internal endogenous cannabinoids known as endocannabinoids in the gut allowed inflammation to occur in the mice. The researchers concluded that adding cannabinoids from cannabis plant sources such as marijuana could be why so many IBS (inflammatory bowel syndrome) and Celiac Disease sufferers experience powerful relief from cannabis. Lead study author McCormick's phrase "This gives clinical researchers a new drug target …" seems to imply that the intent of this study was to develop drugs for the pharmaceutical industry. Natural whole medical cannabis plants, which offer a plethora of disease cures that Big Pharma cannot offer, are not able to be patented. Knowledge of cannabis’s multiple uses is already beginning to impinge on the pharma cartel’s highly profitable medical monopoly, which relies on creating a synthetic version the active pharmacological component of a natural source to patent it. There is hope for sanity to prevail eventually, enabling cannabis to be readily available as a natural medicine for the many ailments and autoimmune diseases once considered incurable by mainstream medicine.